Availability and use of PET in patients with brain tumours: a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
Positron emission tomography (PET) is increasingly used in neuro-oncology. However, little is known about its application across European institutions and reasons for variable implementation.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
04 June 2025
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2025, Volume: 52, Issue: 12, Pages: 4627-4638 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-025-07366-0 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-025-07366-0 |
| Author Notes: | Maximilian J. Mair, Philipp Lohmann, Norbert Galldiks, Mattias Belting, Petter Brandal, Martinus P.G. Broen, Francesco Cicone, Jean-François Daisne, François Ducray, Felix Ehret, Julia Furtner, Asgeir S. Jakola, Maximilian Niyazi, Alessia Pellerino, Marika Rasschaert, Evangelia Razis, Felix Sahm, Marion Smits, Nelleke Tolboom, Antoine Verger, Emilie Le Rhun, Giuseppe Minniti, Michael Weller, Matthias Preusser, Nathalie L. Albert |
| Summary: | Positron emission tomography (PET) is increasingly used in neuro-oncology. However, little is known about its application across European institutions and reasons for variable implementation. |
|---|---|
| Item Description: | Gesehen am 05.11.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-025-07366-0 |